PK Flashcards
F of High ER hepatic drugs are very sensitive to changes in ER
Yes.
F=1-ER
E.g. for ER 0.8, F =0.2
If ER decreased to 0.6, due to liver function impaired, F =0.4 ( which doubles)
PHASE I of liver metabolism involve:
Oxidation
Hydrolysis
Phase II of liver metabolism involves:
- Conjugation
2. Acetylation
If the metabolites are active, it would have:
Cummulative effects,
May leads to toxicity (such as panadol—>NAPQI)
Hepatic clearance for high ER drug:
CL= Q×ER
Depend on Q. hepatic flow rate ( flow limited hepatic clearance)
Factors affecting metabolism:
- Pharmacological factors (enzyme inducer or inhibitor)
- Pharmarcogenetic factors; e.g hydroxylation (CYP2D6)
- PHysiological status ( age)
- Pathological Factors ( liver disease)
List some potent inducer
Antiepilectic ( except diazepam)
Rafampicin
Alcohol
Cigarette smoking
Renal extraction rate low drug , renal clearance depends on
Renal GFR (renal function)
For weak acid drugs, in acid urine:
More non-ionized, more be reabsorbed to plasma.
Slower the clearance
In order to clear weak acid drugs, the urine should be:
Alkaline.
More ionized acid drug, more be excreted in urine
To clear weak base drugs, the urine should be
Acid.
Weak base drug in acid environment, more ioned, more to be excreted in urine
Factors afftecting renal clearance
- Urine pH
- URINE FLOW ( higher flow rate dilute drug comc and reduces reabsorption)
- Plasma protein bonding ( as only unbond drugs are filtered through GF)
- Competition for tubular secretion ( such as competing for the acid pump)
- State of renal function: ClCr
Calculate T1/2
T1/2= 0.693x Vd/Cl
What are thr barriers or factors to drugs movement, before reaching to site of action?
- Blood flow
- Blood permeability
- Interstitial compartments ( e.g. albumin)
- Cell membrane and cytoplasm
- The environment, including aqueous (blood) and lipid ( fatty tissues)
- Blood brain barrier
- Properties of the drug
Fsctors influencing individual response to drugs (dosage to effect relationship)
- Patient compliance
- pk: Absorption ( the ratr and the extent, i.e. F),
- distributiom ( binding to inactive site; body size anf composition; entry into body compartment)
- Metabolism/ biotransformation
- Excretion
( PK affted the PDC) - Concentration at sites of action( tissue responsiveness, functional states, psychological states, placebo effects)
- Pharmacological effects - therapeutic(clinical useful)
- subtherapeutic (too low PDC)
- Adverse effects (avoidable or unavoidable)
-toxic (overdose, PDC too high)
PK AND PD is affected by # physiological variables # pathological factors # genetic factors # environmental factors ( pomelo as ezyme inducer) # development of tolerance # dosage form # route of administration # DDI